electroCore, Inc.
ECOR Nasdaq Electromedical & Electrotherapeutic Apparatus Financials FY2017βFY2025
What electroCore, Inc. does
No business description yet.
- Legal name
- electroCore, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 19, 2026
- Accession Β· CIK
- 0001493152-26-011636
0001560258
Revenue and margins
electroCore, Inc. had $32.0M of revenue in fiscal 2025, up 27.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$8.3M in fiscal 2025, β25.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
electroCore, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 13.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably electroCore, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $34.7M | $17.7M | $10.3M | $12.2M | $11.6M |
| Debt incl. finance leases | β | β | β | β | $7.8M |
| Interest coverage | β | β5,718.5x | β | β661.0x | β882.8x |
| Current ratio | 6.8x | 3.0x | 1.8x | 1.8x | 1.4x |
| Quick ratio | 6.6x | 2.7x | 1.5x | 1.6x | 1.2x |
| Total assets | $42.8M | $24.8M | $16.1M | $20.5M | $18.7M |
| Total liabilities | $6.2M | $7.7M | $8.7M | $12.9M | $20.4M |
| Shareholders' equity | $36.6M | $17.1M | $7.4M | $7.5M | β$1.7M |
| Net debt (β = net cash) | β | β | β | β | β$3.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 3 / 8 | 4 / 8 | 6 / 8 | 3 / 8 | 3 / 8 | 6 / 8 | 3 / 8 |
| Accruals ratio | β26.7% | β15.5% | β0.1% | β10.3% | β9.7% | β16.3% | β20.4% | β27.0% | β29.5% |
| Altman Z'' | β26.31 | 8.57 | β10.78 | β9.28 | β1.47 | β19.40 | β38.07 | β29.29 | β36.67 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $0.8M | $1.0M | $2.4M | $3.5M | $5.5M | $8.6M | $16.0M | $25.2M | $32.0M |
| Gross profit | $0.3M | $0.4M | $1.2M | $1.8M | $4.1M | $7.0M | $13.2M | $21.4M | $27.8M |
| Research and development | $7.8M | $12.5M | $9.9M | $4.2M | $2.5M | $5.5M | $5.3M | $2.4M | β |
| Operating income | β$25.6M | β$54.6M | β$46.1M | β$24.7M | β$20.0M | β$22.9M | β$19.3M | β$12.2M | β$13.2M |
| Interest expense | $6.3M | β | $0.0M | $0.0M | β | $0.0M | β | $0.0M | $0.0M |
| Pretax income | β$36.0M | β$55.8M | β$45.1M | β$24.7M | β$18.1M | β$22.6M | β$19.0M | β$12.0M | β$14.0M |
| Income tax | β | $0.0M | $0.0M | β$1.2M | β$0.9M | β$0.4M | β$0.2M | β$0.1M | $0.0M |
| Net income | β$35.8M | β$55.8M | β$45.1M | β$23.5M | β$17.2M | β$22.2M | β$18.8M | β$11.9M | β$14.0M |
| Net income to common | β | β | β | β | β$17.2M | β$22.2M | β$18.8M | β | β |
| Diluted EPS | β | β$1.19 | β$1.54 | β$0.60 | β$4.36 | β$4.69 | β$3.42 | β$1.59 | β$1.65 |
| Diluted shares | β | 0.03B | 0.03B | 0.04B | 0.00B | 0.00B | 0.01B | 0.00B | 0.00B |
| Cash flow | |||||||||
| Cash from operations | β$25.3M | β$47.1M | β$45.1M | β$20.1M | β$13.6M | β$16.6M | β$14.7M | β$6.9M | β$8.2M |
| Capital expenditure | $0.2M | $0.3M | $0.1M | β | β | β | $0.2M | β | $0.1M |
| Free cash flow | β$25.5M | β$47.4M | β$45.1M | β | β | β | β$14.9M | β | β$8.3M |
| Depreciation and amortization | $0.0M | $0.1M | $0.2M | $0.4M | $0.4M | $0.5M | $1.0M | $0.8M | $0.5M |
| Stock-based compensation | $0.5M | $7.6M | $3.9M | $3.3M | $3.3M | $2.7M | $1.7M | $1.9M | $1.9M |
| Balance sheet | |||||||||
| Cash and short-term investments | $37.2M | $68.6M | $24.1M | $22.6M | $34.7M | $17.7M | $10.3M | $12.2M | $11.6M |
| Total debt | β | β | β | $1.4M | β | β | β | β | $7.8M |
| Current assets | $39.0M | $72.7M | $26.5M | $25.1M | $37.5M | $21.2M | $14.3M | $16.3M | $15.7M |
| Current liabilities | $6.1M | $7.1M | $9.1M | $5.9M | $5.5M | $7.0M | $8.1M | $9.2M | $11.3M |
| Inventory | $0.3M | $1.9M | $0.9M | $0.9M | $1.4M | $2.0M | $2.2M | $1.7M | $1.6M |
| Property and equipment, net | $0.2M | $0.4M | $0.3M | $0.2M | $0.1M | $0.1M | $0.2M | $0.2M | $0.4M |
| Total assets | $39.2M | $73.5M | $35.5M | $31.5M | $42.8M | $24.8M | $16.1M | $20.5M | $18.7M |
| Total liabilities | $6.4M | $7.3M | $10.6M | $7.9M | $6.2M | $7.7M | $8.7M | $12.9M | $20.4M |
| Shareholders' equity | β$90.1M | $65.6M | $24.3M | $23.0M | $36.6M | $17.1M | $7.4M | $7.5M | β$1.7M |
| Margins | |||||||||
| Gross margin | 36.1% | 41.7% | 51.6% | 50.3% | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% |
| Operating margin | β3,160.1% | β5,493.8% | β1,928.1% | β707.9% | β367.7% | β266.2% | β120.2% | β48.3% | β41.1% |
| EBITDA margin | β3,156.2% | β5,487.1% | β1,917.7% | β696.5% | β360.7% | β259.8% | β114.2% | β45.3% | β39.5% |
| Net margin | β4,410.6% | β5,621.4% | β1,888.8% | β672.6% | β315.9% | β257.9% | β117.5% | β47.2% | β43.6% |
| FCF margin | β3,140.1% | β4,772.3% | β1,888.3% | β | β | β | β92.8% | β | β25.8% |
| Returns | |||||||||
| Return on capital | β | β | β | β1,092.0% | β | β | β | β | β |
| Return on capital employed | β77.4% | β82.1% | β175.1% | β96.6% | β53.7% | β129.2% | β241.5% | β107.4% | β179.7% |
| Return on equity | β | β | β100.5% | β99.5% | β57.7% | β82.5% | β153.6% | β158.6% | β478.7% |
| Return on assets | β91.2% | β99.0% | β82.9% | β70.2% | β46.3% | β65.6% | β92.2% | β65.0% | β71.4% |
| Return on tangible equity | β | β85.2% | β186.1% | β102.2% | β47.0% | β129.7% | β253.1% | β157.6% | β |
| Growth | |||||||||
| Revenue growth | β | 22.4% | 140.7% | 46.2% | 55.9% | 57.6% | 86.6% | 57.1% | 27.2% |
| Share count change | β | β | 0.4% | 32.7% | β100.0% | 20.5% | 117,240.4% | β99.9% | 13.3% |
| Financial health | |||||||||
| Debt / equity | β | β | β | 0.1x | β | β | β | β | β |
| Interest coverage | β4.1x | β | β13,168.1x | β82,495.0x | β | β5,718.5x | β | β661.0x | β882.8x |
| Current ratio | 6.4x | 10.3x | 2.9x | 4.3x | 6.8x | 3.0x | 1.8x | 1.8x | 1.4x |
| Quick ratio | 6.3x | 10.0x | 2.8x | 4.1x | 6.6x | 2.7x | 1.5x | 1.6x | 1.2x |
| Capital allocation | |||||||||
| Capex / revenue | 18.8% | 28.1% | 2.9% | β | β | β | 1.3% | β | 0.2% |
| Stock comp / revenue | 57.0% | 765.3% | 163.0% | 93.4% | 60.6% | 31.2% | 10.6% | 7.4% | 6.0% |
| Quality scores | |||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 4.0 | 6.0 | 3.0 | 3.0 | 6.0 | 3.0 |
| Altman Z'' | β26.3 | 8.6 | β10.8 | β9.3 | β1.5 | β19.4 | β38.1 | β29.3 | β36.7 |
| Accruals ratio | β26.7% | β15.5% | β0.1% | β10.3% | β9.7% | β16.3% | β20.4% | β27.0% | β29.5% |
Source: SEC EDGAR XBRL filings (CIK 0001560258). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.